Co-Founder and CEO
Lana Feng is the Co-Founder and CEO of Huma.AI. She has led the company from inception to growth phase post series A, providing its generative AI platform to Pharma and life science companies to automate manual data curation and eliminate data bottlenecks in medical affairs, clinical development, RWE, and post-market surveillance.
Dr. Feng spent over 20 years in precision medicine. Dr. Feng, before founding Huma.Al, she came from Novartis Oncology Business Unit where she established international partnerships for their targeted cancer therapeutics programs. She joined Novartis through its acquisition of Genoptix. Dr. Feng built the BioPharma division at Genoptix, where she grew the business from zero to $45M in five years by forging alliances with pharmaceutical companies and providing companion diagnostics development for targeted cancer therapies. The division was instrumental in Genoptix’ acquisition by Novartis for $500M.